Buyer profile
The Royal Marsden NHS Foundation Trust
Get alerts when The Royal Marsden NHS Foundation Trust publishes a new tender — 7-day free trial, then £4.99/month.
Total contracts
32
Known spend
£50m
31 disclosed
Average value
£2m
Per contract
Active suppliers
10
Last 5 years
Top suppliers
Last 5 years- 1
Nonacus
2 winslatest 21 Aug 2025£2m
- 2
Integrated DNA Technologies
2 winslatest 07 Nov 2025£1m
- 3
NHS BLOOD AND TRANSPLANT (NHSBT)
2 winslatest 16 May 2025£35,000
- 4
Inhealth Limited
1 winlatest 21 Sept 2026£28m
- 5
Community Ambulance Service Limited
1 winlatest 27 Mar 2025£4m
- 6
Siemens Healthcare LTD
1 winlatest 05 Feb 2026£2m
- 7
Xiel Ltd
£1m
- 8
Adaptive Biotechnologies Corporation
1 winlatest 30 Dec 2025£1m
- 9
SkylineDx BV
1 winlatest 19 Mar 2026£635,890
- 10
ELITech UK Ltd
£473,673
What they buy
By CPV categoryHealth & social workCPV 85
6 contracts · £33m
Public utilitiesCPV 65
1 contract · £1m
Community & personal servicesCPV 98
1 contract · £246,787
Repair & maintenanceCPV 50
1 contract · £182,267
Business servicesCPV 79
1 contract · £161,033
SoftwareCPV 48
1 contract · £122,400
Architectural & engineeringCPV 71
1 contract · £45,600
Construction worksCPV 45
1 contract
Tender activity
Notices published per month — last 24 months
All contracts (32)
RMH - CAR-T treatment
CAR-T treatment called Obecel developed to treat relapsed or refractory B-cell precursor acute lymphoblastic leukaemia (r/r B-ALL) which has recently become available to patients.
Clinical trial data management system
The Authority is seeking to procure a new Clinical Trial Data Management Solution. The primary objective of this solution is to provide an accessible and cost-effective service tha
Nonacus galeas hereditaryplus panel
The purchasing of a Nonacus GALEAS HereditaryPlus panel and GALEAS HereditaryPlus Variant Calling with field application scientist support
Supply of truseq compatible duplex Y adaptors
The Laboratory at RMH is currently using these DNA adaptors for high throughput sequencing experiments. These reagents are required to deliver a service. The adaptors have been val
(RMH) - stem cell & immunotherapy services
Direct Award A - single source PSR - Direct A
RMH - provision of pathology diagnostics service
Urgent award - PSR Being awarded to incumbent provider and will procure next year SWLP shall provide a comprehensive diagnostic pathology service for specimens received from the Pu
RMH - provision of haematopoietic progenitor cells
for the the supply of paediatric bone marrow harvests- a highly specialist procedure that’s conducted in a limited number of Trusts within the UK for our cohort of Paediatric patie
Clinical trial database management system
The overarching aim of this solution is to deliver an accessible and cost-effective service, which enables The Royal Marsden to collect and manage clinical research data in complia
(RMH) - extracorporeal photopheresis services
SLA between NHS Blood & Transplant (supplier) and RMH (customer) for the the provision of Extracorporeal Photopheresis services for the treatment of chronic and acute Graft versus
Non emergency patient transport -chelsea and westminster hospital
Chelsea and Westminster Hospital NHS Foundation Trust ("the Authority") required the provision of Non-Emergency Patient Transport Services. The Authority intends to award a contrac
The royal marsden hospital the oak cancer centre
The Works shall be known as The Oak Cancer Centre. The building comprises six levels in total (Lower Ground, Ground and Levels 1 to 4). The design proposes a reinforced concrete fr
Invitation to tender for the provision of a stem cell clinical and laboratory IT system
The Royal Marsden NHS Foundation Trust is a Centre of Excellence for stem cell 1.8transplantation and has one of the largest stem cell transplant programmes in the UK with over 200